US Patent 7312333 Retroviral protease inhibitors
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Daniel P. Getman0
Donald J. Rogier, Jr.0
Gary A. DeCrescenzo0
John J. Talley0
John N. Freskos0
Kathryn L. Reed0
Ko-Chung Lin0
Michael Clare0
Michael L. Vazquez0
Richard A. Mueller0
Robert M. Heintz0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+173 characters)
Article
Patent abstract
N-heterocyclic moiety containing hydroxyethylamine compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07312333 Retroviral protease inhibitors US Patent 7312333 Retroviral protease inhibitors
Infobox
Patent Number
073123330
Patent Number
73123330
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
073123330
Date of Patent
December 25, 2007
0Patent Application Number
113313440
Date Filed
January 13, 2006
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07312333 Retroviral protease inhibitors
Infobox
Is a
Patent jurisdiction
Patent number
07312333
Date of patent
December 25, 2007
Patent application number
11331344
Date Filed
January 13, 2006
Patent primary examiner
Find more entities like US Patent 7312333 Retroviral protease inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
